Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

BACKGROUND: Rituximab inhibited structural damage at 1 year in patients with rheumatoid arthritis (RA) who had had a previous inadequate response to tumour necrosis factor (TNF) inhibitors. OBJECTIVE: To assess structural damage progression through 2 years. METHODS: Intention-to-treat patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Stanley B, Keystone, Edward, Genovese, Mark C, Emery, Paul, Peterfy, Charles, Tak, Paul Peter, Cravets, Matt, Shaw, Tim, Hagerty, David
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935326/
https://www.ncbi.nlm.nih.gov/pubmed/20439295
http://dx.doi.org/10.1136/ard.2009.119222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935326/
https://www.ncbi.nlm.nih.gov/pubmed/20439295
http://dx.doi.org/10.1136/ard.2009.119222

Ejemplares similares